Vascular Involvement and Resectability of Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced MRI: Comparison with Pancreatic Protocol CT
Yoshifumi Noda1, Nobuyuki Kawai1, Avinash R. Kambadakone2, Tetsuro Kaga1, Takuma Ishihara3, Fuminori Hyodo4, Hiroki Kato1, and Masayuki Matsuo1
1Department of Radiology, Gifu University, Gifu, Japan, 2Department of Radiology, Massachusetts General Hospital, Boston, MA, United States, 3Innovative and Clinical Research Promotion Center, Gifu University Hospital, Gifu, Japan, 4Department of Radiology, Frontier Science for Imaging, Gifu University, Gifu, Japan
MRI is used as a problem-solving tool when contrast-enhanced CT is not available for assessing pancreatic ductal adenocarcinoma. In this study, we evaluated the diagnostic performance of vascular involvement and resectability on MRI and compared them with pancreatic protocol CT. Our results showed that no statistical difference in terms of the detection of vascular involvement and the resectability classification based on the NCCN guideline between CT and MRI.
This abstract and the presentation materials are available to members only;
a login is required.